Observation study to asses the effect of SGLT2 inhibitors on cardiac uptake of FDG
Not Applicable
Recruiting
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0004869
- Lead Sponsor
- lsan Univeristy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Patient is being treated with SGLT2 inhibitor for type 2 diabetes
2. Patient has been diagnosed with lymphoma or multiple myeloma by a hemato-oncologist
3. Patient is scheduled to undergo [18F]FDG PET/CT exam
Exclusion Criteria
1. Patient has atrial fibrillation or history of cardiovascular event within the last 6 months
2. Patient is using insulin or has a history of using insulin
3. Uncontrolled hypertension (>160/110)
4. Pregnancy
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual scoring of cardiac uptake of fluorodeoxyglucose
- Secondary Outcome Measures
Name Time Method Standardized uptake value of myocardium